APA
MCRB icon

American Portfolios Advisors’s Seres Therapeutics MCRB Stock Holding History

American Portfolios Advisors’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-865
Closed -$413K – 3517
2021
Q2 		$413K Buy
865
+17
+2% +$7.17K 0.02% 807
2021
Q1 		$349K Buy
848
+140
+20% +$64.5K 0.02% 805
2020
Q4 		$347K Buy
708
+241
+52% +$141K 0.02% 677
2020
Q3 		$265K Buy
467
+246
+111% +$81.8K 0.02% 696
2020
Q2 		$21K Buy
221
+170
+333% +$14.9K ﹤0.01% 1623
2020
Q1 		$3.65K Buy
+51
New +$3.42K ﹤0.01% 2212
2019
Q4 		– Sell
-7
Closed -$557 – 2891
2019
Q3 		$557 Hold
7
– – ﹤0.01% 2704
2019
Q2 		$448 Buy
+7
New +$664 ﹤0.01% 2655

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Portfolios Advisors's MCRB Position: Q3 2021 in Review

American Portfolios Advisors sold out of Seres Therapeutics (MCRB) in Q3 2021, closing a stake of 865 shares — an estimated $413K sold.

American Portfolios Advisors first reported a position in MCRB in Q2 2019 and held it in 8 quarters. The position peaked at $413K in Q2 2021. 133 funds tracked by Wall St. Rank hold MCRB as of Q3 2021.

  • American Portfolios Advisors reported no remaining Seres Therapeutics position as of Q3 2021 after selling out during the quarter.
  • American Portfolios Advisors sold 865 Seres Therapeutics shares in Q3 2021, an estimated $413K.
  • American Portfolios Advisors first reported a position in Seres Therapeutics in Q2 2019 and held it in 8 quarters.
  • American Portfolios Advisors's Seres Therapeutics position peaked at $413K in Q2 2021.
  • 133 funds tracked by Wall St. Rank held Seres Therapeutics as of Q3 2021.

Based on American Portfolios Advisors's 13F filing for Q3 2021, filed 22 Mar 2023.